MedTrace Logo

Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers

NCT07731880 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-08-06

No results posted yet for this study

Summary

This study is being done to determine how easy it is to use standard of care (SOC) surgical resections or biopsy for SmartMatch analysis to determine treatment options in advanced gynecological malignancies.

Conditions

  • Malignant Female Reproductive System Neoplasm
  • Metastatic Malignant Female Reproductive System Neoplasm
  • Unresectable Malignant Female Reproductive System Neoplasm

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Kalyan Banda, MD · Fred Hutch/University of Washington Cancer Consortium

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2029-07-31
Completion
2029-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07731880 on ClinicalTrials.gov